BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Business

  Novozymes Biopharma To Offer Drug-Albumin Conjugation Platform In Collaboration With Thiologics

  May 13, 2014

   · 

  4 min read
• Deals

  Origin Agritech Limited Announces Receipt Of Acquisition Proposal

  May 13, 2014

   · 

  3 min read
• Business

  BIOLASE Inc. Reports 2014 First Quarter Results

  May 13, 2014

   · 

  1 min read
• Rafarma Pharmaceuticals Commences Preparation Of Audited Financials

  May 13, 2014

   · 

  2 min read
• Business

  Dynatronics Corporation To Release Fiscal Third Quarter Results Tuesday, May 13, 2014; Conference Call Set For 1:00 P.M. ET

  May 13, 2014

   · 

  1 min read
• Drug Development

  Provectus Biopharmaceuticals Inc.: Short-Term Catalysts And Positive Trial Results Could Help Shares

  May 13, 2014

   · 

  3 min read
• Business

  Halozyme Therapeutics, Inc. Reports First Quarter 2014 Financial Results

  May 13, 2014

   · 

  1 min read
• Business

  KineMed, Inc. Hires William J. Evans, Ph.D. To Head Muscle And Health Division

  May 13, 2014

   · 

  1 min read
• Business

  Idera Pharmaceuticals, Inc. Reports First Quarter 2014 Financial Results And Provides Update On Key Programs And Business Strategy

  May 13, 2014

   · 

  1 min read
• Drug Development

  Alnylam Pharmaceuticals Reports Initial Positive Top-Line Data From Phase 1 Clinical Trial With ALN-AT3, An RNAi Therapeutic Targeting Antithrombin (AT) In Development For The Treatment Of Hemophilia And Rare Bleeding Disorders (RBD)

  May 13, 2014

   · 

  19 min read